Hear from the below dynamic keynotes on:
- Multi-specific Biologics
Robert Friesen, Ph.D., Janssen R&D, LLC (Johnson & Johnson), USA
- Antibody Lead Discovery & Optimization
Rene Hoet, Ph.D. Bayer Healthcare, Germany
- Analytical Control from Phase I to Post Approval
Sherry Guo, Ph.D. F. Hoffmann-La Roche Ltd., USA
- And more!
Share this article with your social network, just click below to share now!